India Administers Over 80 Lakh HPV Vaccine Doses in Nationwide Cervical Cancer Prevention Campaign

India has administered more than 80 lakh human papillomavirus vaccinations under its nationwide immunization campaign, marking a major milestone in adolescent preventive healthcare and cervical cancer mitigation. The Union Ministry of Health and Family Welfare announced the achievement, highlighting the steady expansion of public health delivery networks targeting preventable cancers across diverse geographic regions.

The nationwide initiative was originally launched by Prime Minister Narendra Modi on February 28, targeting 14-year-old girls across the country. Under the established guidelines, the single-dose Gardasil-4 vaccine is distributed free of charge through public health facilities, including Ayushman Arogya Mandirs, primary health centers, community health centers, district hospitals, and government medical colleges.

State-level participation in the nationwide campaign has varied, with several regional health administrations recording high uptake and complete coverage of their identified cohorts. According to official figures released by health authorities, Gujarat, Uttar Pradesh, Madhya Pradesh, and Mizoram have achieved full 100 percent coverage of their targeted adolescent populations. Meanwhile, Bihar, Andhra Pradesh, and Assam have crossed the 90 percent immunization threshold, while Karnataka has surpassed 85 percent coverage.

Additional states including Chhattisgarh, Sikkim, Kerala, Telangana, and Odisha have exceeded 60 percent coverage under the ongoing rollout. Among all administrative regions, Uttar Pradesh recorded the highest absolute volume of vaccinations, with more than 22 lakh adolescent girls immunized. Health authorities attributed these coverage figures to sustained community mobilization, active participation from district health teams, and context-specific delivery strategies designed to reach remote and geographically challenging areas.

The administration of doses is strictly regulated under the supervision of trained medical officers at designated government facilities. Mandatory parental consent is required prior to vaccination, and beneficiaries register their participation through the centralized U-WIN digital health platform, which allows program managers to track district-level coverage and identify potential gaps.

To address safety concerns, vaccination sites are linked to 24x7 adverse events following immunization management centers. These facilities provide prompt assessment and management for any rare adverse occurrences. Healthcare providers, pediatricians, gynecologists, and frontline workers such as Accredited Social Health Activists and Auxiliary Nurse Midwives have been mobilized to conduct community awareness programs and counter vaccine hesitancy.

The campaign's progress coincides with recent legal developments regarding its implementation framework. The Delhi High Court declined to issue an interim stay against the ongoing HPV vaccination drive, observing that the petition failed to establish sufficient grounds to suspend the nationwide public health program at this stage of proceedings.

However, the bench emphasized that all regulatory protocols and safety procedures must be strictly enforced before any vaccine is administered to participants. The court formally sought comprehensive responses from the Union government, the Central Drugs Standard Control Organisation, and the Indian Council of Medical Research concerning the operational safeguards governing the rollout.

Public health officials note that the national rollout aligns with extensive international experience involving human papillomavirus immunization. More than 800 million doses of HPV vaccines have been distributed globally, providing substantial real-world data regarding their efficacy and safety profiles across diverse populations and healthcare systems.

Statistical data compiled by international health agencies indicates that HPV vaccination programs have been integrated into national immunisation schedules in 87 percent of upper-middle-income countries, 78 percent of lower-middle-income countries, and 54 percent of low-income countries worldwide. As the Indian campaign advances toward its concluding phases, health authorities continue coordinating with local bodies and school networks to reach remaining eligible beneficiaries.